HROWL Company Profile and Key Details
NASDAQ : HROWL
Harrow Health 8625% Senior Notes due 2026
$25.61
0.0478+0.19%
Open: 4:00 PMNot Actively Trading
Price Chart
Stock Price Today
Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) stock surged +0.19%, trading at $25.61 on NASDAQ, up from the previous close of $25.56. The stock opened at $25.56, fluctuating between $25.53 and $25.63 in the recent session.
Stock Snapshot
25.5622
Prev. Close
1.37B
Market Cap
25.53
Day Low
0
P/E Ratio
0
EPS (TTM)
-4.21
Cash Flow per Share
25.56
Open
53.36M
Number of Shares
25.625
Day High
83.4%
Free Float in %
1.99
Book Value
7.66K
Volume
Relevant Articles
SEC Fillings
Current Report (8-k)
| Filing Date | Accepted Date | |
|---|---|---|
Annual Report (10-k)
| Filing Date | Accepted Date | |
|---|---|---|
Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 10, 2025 | 25.55 | 25.61 | 25.53 | 25.61 | 7.67K |
| Oct 09, 2025 | 25.55 | 25.65 | 25.54 | 25.56 | 16.87K |
| Oct 08, 2025 | 25.57 | 25.64 | 25.55 | 25.55 | 16.65K |
| Oct 07, 2025 | 25.51 | 25.60 | 25.39 | 25.57 | 21.17K |
| Oct 06, 2025 | 25.63 | 25.64 | 25.59 | 25.63 | 9.84K |
| Oct 03, 2025 | 25.61 | 25.65 | 25.58 | 25.65 | 16.88K |
| Oct 02, 2025 | 25.58 | 25.60 | 25.58 | 25.60 | 10.67K |
| Oct 01, 2025 | 25.56 | 25.70 | 25.56 | 25.58 | 6.96K |
| Sep 30, 2025 | 25.69 | 25.72 | 25.68 | 25.72 | 9.12K |
| Sep 29, 2025 | 25.67 | 25.69 | 25.67 | 25.68 | 9.6K |
| Sep 26, 2025 | 25.65 | 25.69 | 25.65 | 25.69 | 22.94K |
| Sep 25, 2025 | 25.57 | 25.65 | 25.57 | 25.65 | 25.3K |
| Sep 24, 2025 | 25.66 | 25.66 | 25.42 | 25.57 | 32.22K |
| Sep 23, 2025 | 25.68 | 25.68 | 25.66 | 25.68 | 13.05K |
| Sep 22, 2025 | 25.66 | 25.68 | 25.66 | 25.66 | 17.63K |
| Sep 19, 2025 | 25.52 | 25.68 | 25.52 | 25.66 | 58.75K |
| Sep 18, 2025 | 25.58 | 25.66 | 25.58 | 25.65 | 18.11K |
| Sep 17, 2025 | 25.67 | 25.68 | 25.65 | 25.66 | 14.52K |
| Sep 16, 2025 | 25.65 | 25.67 | 25.64 | 25.65 | 18.59K |
| Sep 15, 2025 | 25.64 | 25.69 | 25.64 | 25.65 | 31.27K |
Contact Details
About Company
Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Its business activities are primarily divided into two segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding division notably encompasses the operations of the ImprimisRx business. Co-founded by Mark L. Baum and Robert J. Kammer in January 2006, the firm maintains its corporate headquarters in Nashville, Tennessee.
Company Information
| Employees | 217 |
| Beta | 0.14 |
| Sales or Revenue | $130.19M |
| 5Y Sales Change% | 1.297% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Pharmaceuticals |
Stock Peers
CORT
4.08+4.46%
Corcept Therapeutics Incorporated$95.65LQDA3.81+4.94%
Liquidia Corporation$80.89KNSA0.97+1.55%
Kiniksa Pharmaceuticals International, plc$63.55RPRX1.125+1.96%
Royalty Pharma plc$58.42AVLN0.4+1.40%
Avalyn Pharma Inc. Common Stock$29.03HROWM-0.02-0.08%
Harrow Health, Inc. 11.875% Senior Notes due 2027$26.03XOMAP00
XOMA Royalty Corporation$24.98LFMDP-0.09-0.39%
LifeMD, Inc.$23.26GLTO-0.75-3.36%
Galecto, Inc.$21.58CGEM0.56+3.20%
Cullinan Therapeutics, Inc.$18.06Company Overview
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL) closed at $25.61 USD, gaining $0.05 (0.19%) from the previous close of $25.56. The stock is currently trading near its 52-week high $25.00 and $25.72. With a market capitalization of about $1.37 billion, Harrow Health, Inc. 8.625% Senior Notes due 2026 is classified as a small-cap and shows lower-than-market volatility (beta ~0.14). Key stats such as the average daily volume over the past year has been around 16.25 thousand shares, volume is running light vs its 52-week average. Headquartered in Nashville, DE, Harrow Health, Inc. 8.625% Senior Notes due 2026 operates in the Healthcare sector and the Medical - Pharmaceuticals industry. Led by CEO Mark L. Baum, the company employs approximately 217 people and listed since May 07, 2021. Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications.
Technical Performance
HROWL has shown mixed momentum, losing -0.62% over the past week and -0.95% over the past quarter, though year-to-date performance is down -0.95%.
Valuation Metrics
Harrow Health, Inc. 8.625% Senior Notes due 2026 trades at a P/E ratio of -111.15, slightly below the S&P 500 average, with a price-to-sales ratio of 6.05 and a price-to-book ratio of 56.58 reflecting a rich premium to book value. The P/FCF stands at 113.89, also above market averages. Compared to sector medians, Harrow Health, Inc. 8.625% Senior Notes due 2026 P/S is trading rich, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.
Dividend & Fair Value
Harrow Health, Inc. 8.625% Senior Notes due 2026 last paid a dividend of 1.62 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.00.
Earnings & Analyst Outlook
Harrow Health, Inc. 8.625% Senior Notes due 2026 earnings surprise history is a mixed track record. The quarter that ended August 11, 2025, missed forecasts by 1603.31%. The prior quarter beat by 978.89%. Over the last six quarters, Apple has recorded several small beats. These include 75.83% in May 13, 2024.
Frequently Asked Questions
What is the current Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) stock price?
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ: HROWL) stock price is $25.61 in the last trading session. During the trading session, HROWL stock reached the peak price of $25.63 while $25.53 was the lowest point it dropped to. The percentage change in HROWL stock occurred in the recent session was 0.19% while the dollar amount for the price change in HROWL stock was $0.05.
HROWL's industry and sector of operation?
The NASDAQ listed HROWL is part of Medical - Pharmaceuticals industry that operates in the broader Healthcare sector. Harrow Health, Inc. 8.625% Senior Notes due 2026 designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of HROWL?
No Data
How HROWL did perform over past 52-week?
HROWL's closing price is 2.44% higher than its 52-week low of $25.00 where as its distance from 52-week high of $25.72 is -0.43%.
How many employees does HROWL have?
Number of HROWL employees currently stands at 217.
Link for HROWL official website?
Official Website of HROWL is: http://www.harrowinc.com
How do I contact HROWL?
HROWL could be contacted at phone 0 and can also be accessed through its website. HROWL operates from , Nashville, DE , United States.
How many shares of HROWL are traded daily?
HROWL stock volume for the day was 7.66K shares. The average number of HROWL shares traded daily for last 3 months was 16.25K.
What is the market cap of HROWL currently?
The market value of HROWL currently stands at $1.37B with its latest stock price at $25.61 and 53.36M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep